- Human papillomavirus vaccine in boys: background rates of potential adverse eventsHazel J Clothier
Surveillance of Adverse Events Following Vaccination in the Community SAEFVIC, Murdoch Childrens Research Institute, Melbourne, Vic
Med J Aust 198:554-8. 2013..To determine background rates of potential adverse events following immunisation (AEFI) before expansion of the quadrivalent human papillomavirus (4vHPV) vaccination program to adolescent boys...
- Surveillance of adverse events following immunisation: the model of SAEFVIC, VictoriaHazel J Clothier
SAEFVIC, Murdoch Childrens Research Institute, Parkville, Victoria
Commun Dis Intell 35:294-8. 2011..6 per 100,000 in 2003 to 13.5 per 100,000 per annum in 2009. This report describes the SAEFVIC service model and summarises outcomes and lessons learnt in the first 3 years of operation...
- Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case seriesNigel W Crawford
Royal Children s Hospital, Melbourne, Vic, Australia
Med J Aust 197:574-8. 2012..To determine the relative incidence (RI) of Guillain-Barré syndrome (GBS) in a single Australian state following pandemic (H1N1) 2009 influenza A immunisation (monovalent vaccine or seasonal trivalent influenza vaccine [TIV]) in 2009-2010...
- Syncope and seizures following human papillomavirus vaccination: a retrospective case seriesNigel W Crawford
Murdoch Childrens Research Institute, Melbourne, Vic, Australia
Med J Aust 194:16-8. 2011..To quantify and characterise the reports of syncope and seizures following quadrivalent (4v) human papillomavirus (HPV) vaccination...